Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1922 1
1923 1
1928 1
1930 1
1934 1
1941 1
1943 2
1950 1
1975 1
1994 1
2004 1
2006 2
2007 3
2008 2
2010 2
2011 1
2012 3
2013 3
2014 2
2015 2
2016 2
2017 3
2018 5
2019 3
2020 9
2021 10
2022 3
Text availability
Article attribute
Article type
Publication date

Search Results

59 results
Results by year
Filters applied: . Clear all
Page 1
The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Among authors: barbour t. Kidney Int. 2020 Jun;97(6):1287-1296. doi: 10.1016/j.kint.2020.01.035. Epub 2020 Mar 6. Kidney Int. 2020. PMID: 32299680 Free article. Clinical Trial.
Corrigendum to "Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D and Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment." Kidney Int. 2020;97:1287-1296.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Among authors: barbour t. Kidney Int. 2021 May;99(5):1244. doi: 10.1016/j.kint.2021.03.008. Kidney Int. 2021. PMID: 33892867 No abstract available.
Erratum to "Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon S-S, Kavanagh D, Haller H; on behalf of the 311 Study Group. The long-acting C5 inhibitor, Ravulizumab, is effective and safe in adult patients with atypical hemolytic uremic syndrome naïve to complement inhibitor treatment" Kidney Int. 2020;97:1287-1296.
Rondeau E, Scully M, Ariceta G, Barbour T, Cataland S, Heyne N, Miyakawa Y, Ortiz S, Swenson E, Vallee M, Yoon SS, Kavanagh D, Haller H; 311 Study Group. Rondeau E, et al. Among authors: barbour t. Kidney Int. 2020 Dec;98(6):1621. doi: 10.1016/j.kint.2020.11.001. Kidney Int. 2020. PMID: 33276869 Free article. No abstract available.
The perfect storm.
Ruderman I, Finlay M, Barbour T. Ruderman I, et al. Among authors: barbour t. Kidney Int. 2017 Jul;92(1):267. doi: 10.1016/j.kint.2017.03.049. Kidney Int. 2017. PMID: 28646996 Free article. No abstract available.
Update on C3 glomerulopathy.
Barbour TD, Ruseva MM, Pickering MC. Barbour TD, et al. Nephrol Dial Transplant. 2016 May;31(5):717-25. doi: 10.1093/ndt/gfu317. Epub 2014 Oct 17. Nephrol Dial Transplant. 2016. PMID: 25326473 Free PMC article. Review.
Atypical aHUS: State of the art.
Nester CM, Barbour T, de Cordoba SR, Dragon-Durey MA, Fremeaux-Bacchi V, Goodship TH, Kavanagh D, Noris M, Pickering M, Sanchez-Corral P, Skerka C, Zipfel P, Smith RJ. Nester CM, et al. Among authors: barbour t. Mol Immunol. 2015 Sep;67(1):31-42. doi: 10.1016/j.molimm.2015.03.246. Epub 2015 Apr 3. Mol Immunol. 2015. PMID: 25843230 Review.
Dense deposit disease and C3 glomerulopathy.
Barbour TD, Pickering MC, Terence Cook H. Barbour TD, et al. Semin Nephrol. 2013 Nov;33(6):493-507. doi: 10.1016/j.semnephrol.2013.08.002. Semin Nephrol. 2013. PMID: 24161036 Free PMC article. Review.
Recent insights into C3 glomerulopathy.
Barbour TD, Pickering MC, Cook HT. Barbour TD, et al. Nephrol Dial Transplant. 2013 Jul;28(7):1685-93. doi: 10.1093/ndt/gfs430. Epub 2013 Mar 10. Nephrol Dial Transplant. 2013. PMID: 23479095 Free PMC article. Review.
Management of refractory lupus nephritis: challenges and solutions.
Yo JH, Barbour TD, Nicholls K. Yo JH, et al. Among authors: barbour td. Open Access Rheumatol. 2019 Jul 12;11:179-188. doi: 10.2147/OARRR.S166303. eCollection 2019. Open Access Rheumatol. 2019. PMID: 31372070 Free PMC article. Review.
59 results